PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In a clinical study of 313 patients, the recurrence rate for the Zhuling group (34.9%) was lower than the control group (64.7%) [PMID:11829890]. Another study of 146 patients showed a recurrence rate of 33.3% for Zhuling compared to 65.1% for the control group [PMID:7842985].
Oral administration of aqueous extract of sclerotia in normal rats significantly increased urine output starting at 4 hours [PMID:20083182].
A case report indicated that integrated therapy including Zhu-Ling-Tang helped decrease urinary total protein from 1367.9 mg/24h to 143.6 mg/24h over 143 days [PMID:30012398].
Polysaccharides isolated from mycelia significantly inhibited the growth of H22 implanted tumors in mice [PMID:23648036].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 14987072 (2004) — Biologically active compounds from Aphyllophorales (polypore) fungi. · Journal of natural products
- 2.PMID: 24049465 (2005) — Morphological Characteristics of Hyphal Interaction between Grifola umbellata and its Companion Fungus. · Mycobiology
- 3.PMID: 3059066 (1988) — Traditional Chinese medicine and the search for new antineoplastic drugs. · Journal of ethnopharmacology
- 4.PMID: 37438987 (2023) — An integrated strategy by absorbed component characterization, pharmacokinetics, and activity evaluation for identification of potential nephroprotective substances in Zhu-Ling decoction. · Journal of separation science
- 5.PMID: 39048245 (2024)